openPR Logo
Press release

Direct-acting Antiviral Drugs Market Size, Share, Growth, Forecast | Valuates Reports

01-27-2023 06:38 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Direct Actting Antiviral Drugs Market

The global Direct-acting Antiviral Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, NS3/4A Protease Inhibitors accounting for % of the Direct-acting Antiviral Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

Download Sample Report: https://reports.valuates.com/request/sample/QYRE-Auto-11O2087/Global_Direct_acting_Antiviral_Drugs_Market_Insights_Forecast_to_2028

While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Direct-acting Antiviral Drugs market size is valued at US$ million in 2021, while the North America and Europe Direct-acting Antiviral Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Direct-acting Antiviral Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Direct-acting Antiviral Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Direct-acting Antiviral Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Direct-acting Antiviral Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Direct-acting Antiviral Drugs market.

Direct-acting Antiviral Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Direct-acting Antiviral Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Type
• NS3/4A Protease Inhibitors
• Nucleoside and Nucleotide NS5B Polymerase Inhibitors
• NS5A Inhibitors
• Non-Nucleoside NS5B Polymerase Inhibitors

By Application
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Pharmacies
• Others

By Company
• AbbVie Inc.
• GSK
• Boehringer Ingelheim
• Merck
• Novartis
• Beximco Pharmaceuticals
• Roche
• Bristol-Myers Squibb Company
• Gilead Sciences
• Janssen (Johnson & Johnson)
• Vertex Pharmaceuticals
• Natco Pharma

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-11O2087/global-direct-acting-antiviral-drugs

Similar Reports:

1. HIV Therapeutics Market: https://reports.valuates.com/market-reports/QYRE-Auto-22W5974/global-hiv-therapeutics

2. Antiviral Therapy Market: https://reports.valuates.com/market-reports/QYRE-Auto-2G10409/global-antiviral-therapy

3. Influenza Antiviral Drugs Market: https://reports.valuates.com/market-reports/QYRE-Auto-8J2211/global-influenza-antiviral-drugs

4. Influenza Diagnostics Market: https://reports.valuates.com/reports/QYRE-Auto-13Z613/global-influenza-diagnostics

5. Antiviral Drugs Industry: https://reports.valuates.com/market-reports/QYRE-Othe-2E265/global-antiviral-drugs

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Direct-acting Antiviral Drugs Market Size, Share, Growth, Forecast | Valuates Reports here

News-ID: 2902476 • Views:

More Releases from Valuates Reports

2-Oxazolidinone Market Revenue, Insights, Overview, Outlook, Analysis | Valuates …
2-Oxazolidinone Market Size The global market for 2-Oxazolidinone was valued at US$ 732 million in the year 2024 and is projected to reach a revised size of US$ 916 million by 2031, growing at a CAGR of 3.3% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-1I12558/Global_2_Oxazolidinone_Market?utm_source=Openpr&utm_medium=Referral This report aims to provide a comprehensive presentation of the global market for 2-Oxazolidinone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess
Strontium-88 Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Re …
Strontium-88 Market Size The global market for Strontium-88 was valued at US$ 89 million in the year 2024 and is projected to reach a revised size of US$ 126 million by 2031, growing at a CAGR of 5.2% during the forecast period. Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-34T9158/Global_Strontium_Market?utm_source=Openpr&utm_medium=Referral This report aims to provide a comprehensive presentation of the global market for Strontium-88, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess
Cobalt Sulfate Heptahydrate Market Revenue, Insights, Overview, Outlook, Analysi …
Cobalt Sulfate Heptahydrate Market Size The global market for Cobalt Sulfate Heptahydrate was valued at US$ 449 million in the year 2024 and is projected to reach a revised size of US$ 729 million by 2031, growing at a CAGR of 6.9% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-19T19438/Global_Cobalt_Sulfate_Heptahydrate_Market?utm_source=Openpr&utm_medium=Referral The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments
Ultrasonic Fabric Cutting and Sealing Machine Market Revenue, Insights, Overview …
Ultrasonic Fabric Cutting and Sealing Machine Market Size The global market for Ultrasonic Fabric Cutting and Sealing Machine was valued at US$ 1200 million in the year 2024 and is projected to reach a revised size of US$ 2091 million by 2031, growing at a CAGR of 8.2% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-12M18905/Global_Ultrasonic_Fabric_Cutting_and_Sealing_Machine_Market?utm_source=Openpr&utm_medium=Referral This report aims to provide a comprehensive presentation of the global market for Ultrasonic Fabric Cutting and

All 5 Releases


More Releases for Antiviral

Global Antiviral Therapeutics Market Size - By Product Type(Herpes Antiviral Dru …
Antiviral Therapeutics Market Insights: Trends, Drivers, and Outlook 2024 - 2031 Antiviral Therapeutics Market Scope: Unveiling Today's Trends Antiviral therapeutics are medications designed to treat viral infections by inhibiting viral replication and mitigating symptoms. The Antiviral Therapeutics market is experiencing significant growth, driven by the increasing prevalence of viral diseases, ongoing research and development, and the ongoing impact of emerging viral outbreaks. Key trends include a rising focus on personalized medicine and
Antiviral Drugs Market: Advancements in Antiviral Drugs - Analysis by Medical Ex …
Allied Market Research recently said Antiviral drugs have been at the forefront of medical advancements, offering effective treatment and prevention options against a wide range of viral infections. These pharmaceutical agents are specifically designed to target and inhibit the replication of viruses, helping to control the spread of viral diseases and improve patient outcomes. In recent years, significant progress has been made in the development of antiviral drugs, revolutionizing the
Antiviral Drugs Market
“Antiviral Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market
Antiviral therapies Market: High Cost of Antiviral therapies Is a Major Restrain …
Post COVID-19 Impact on Antiviral Therapies Market –With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues. Research Dive’ group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive
Coronavirus's Impact On Antiviral Packaging Market
Antiviral Packaging Market – An Overview The coronavirus pandemic keeps on revamping the idea of worldwide society in 2020, and with it changes the perspectives and practices of buyers now and for a long time to come. In any case, the prompt effect on buyers’ interests about viral introduction and questions hanging about the infection’s capacity to make due on surfaces, may fuel an any longer enduring interest for new bundling
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an